Neumora Therapeutics, Inc. (NASDAQ:NMRA) is one of the best stocks under $5 with highest upside potential. On October 28, Needham lifted its price target on Neumora Therapeutics, Inc. (NASDAQ:NMRA) to$8 from $6 while keeping a Buy rating on the stock. The firm told investors that it is more optimistic about the company’s outlook after its R&D Investor Event that exhibited its broad pipeline. 5 Fastest Growing Biotech Companies in the US Similarly, Guggenheim upgraded Neumora Therapeutics, Inc. (NASDAQ:N ...